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Purified protein quality control is the final and critical check-point of any protein production process. Unfortunately, it is
too often overlooked and performed hastily, resulting in irreproducible and misleading observations in downstream
applications. In this review, we aim at proposing a simple-to-follow workflow based on an ensemble of widely available
physico-chemical technologies, to assess sequentially the essential properties of any protein sample: purity and
integrity, homogeneity and activity. Approaches are then suggested to optimize the homogeneity, time-stability and
storage conditions of purified protein preparations, as well as methods to rapidly evaluate their reproducibility and
lot-to-lot consistency.
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ComparabilityIntroduction
In recent years, purified proteins have more and more
frequently been used for diagnostic and therapeutic
applications [1-3]. Purified proteins are also widely used
as reagents for downstream in depth biophysical and
structural characterization studies: these are sample- and
time-consuming, generally requiring long set-up phases
and sometimes depending on (limited) accessibility to
large instrumentation such as synchrotrons.
Unfortunately, scientists (especially in the academic
environment) frequently want to rush to the final applica-
tion, considering biochemical analysis of proteins as either
trivial or a superfluous bother. Very often, the implications
of such a regretful attitude are irreproducible, dubious and
misleading results, and unfortunately sometimes lead to
failure at more or less advanced stages (including clinical
trials [4]), with potentially severe consequences. This is
even more the case nowadays, when recombinant produc-
tion of challenging proteins such as integral membrane
proteins or heavily modified (glycosylated, …) proteins is
being attempted on an ever more widespread scale.* Correspondence: bertrand.raynal@pasteur.fr; patrick.england@pasteur.fr
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unless otherwise stated.The correct interpretation of many biophysical/struc-
tural characterization experiments relies on the as-
sumption that:
1) the protein samples are pure and homogeneous.
2) their concentration is assessed precisely.
3) all of the protein is solubilized and in a natively
active state.
Our experience as a core facility dealing with several
dozens of different projects every year is that quality
control considerations are much too often overlooked
or taken for granted by facility users and the scientific
community at large. However, those who assess and
optimize carefully the quality of their protein prepa-
rations significantly increase their chances of success in
subsequent experiments.
Purified protein quality control has already been the
object of several general reviews [5-7]. Attempts have
also been made to define a set of “minimal quality criteria”
that should be fulfilled by any purified recombinantThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Information for Protein Functionality Evaluation” (MIPFE)
consortium [8-10]. In this review, we wish to go one step
further and provide a concise overview of a sequence of
simple-to-follow physico-chemical approaches that should
be accessible to the vast majority of investigators. Most of
the methodologies that are proposed can be found in clas-
sical biochemistry or structural biology laboratories, and in
the majority of institutional protein science core facilities.
Many of the methods and techniques mentioned here are
well known, maybe too well, but clearly need to be reap-
praised in university curricula and laboratory practice:
indeed knowledge about them is generally (and inappro-
priately) regarded as obvious, but very often it is in reality
very sketchy, sometimes unfortunately resulting in gross
blunders. Hopefully, this review will help providing more
robustness to the production of efficient and reliable pro-
tein samples within a large scientific community.
Protein quality control methodological work-flow
Initial Sample assessment
Purity and integrity
Electrophoresis Prior to any downstream experiment,
purity and integrity are the very first qualities that
need to be assessed for any protein sample (Figure 1B).
This is routinely achieved by Sodium Dodecyl Sulfate
Polyacrylamide Gel Electrophoresis (SDS–PAGE). This
technique, associated with Coomassie blue staining, can
detect bands containing as little as 100 ng of protein in
a simple and relatively rapid manner (just a few hours)
[11]. After reduction and denaturation by SDS, proteins
migrate in the gel according to their molecular mass,
allowing to detect potential contaminants, proteolysis
events, etc. However, many low amount impurities and
degradation products can go unnoticed, especially in low
concentration samples or during optimization phases in
which minute aliquots are analysed.
Two higher sensitivity colorimetric staining methods
can be used either directly after electrophoresis or coupled
to Coomassie blue staining: zinc-reverse staining [12] and
silver staining [13]. These can detect as low as 10 ng and
1 ng protein bands respectively. Zinc-reverse staining (also
known as negative staining) uses imidazole and zinc salts
for protein detection in electrophoresis gels [12]. It is
based on the precipitation of zinc imidazole in the gel, ex-
cept in the zones where proteins are located. When zinc-
reverse staining is applied on a Coomassie blue stained
gel, previously undetected bands can be spotted [14]. This
technique is rapid, simple, cheap and reproducible, and is
compatible with mass spectrometry (MS) [15]. On the
other hand, silver staining is based on the binding of silver
ions to the proteins followed by reduction to free silver,
sensitization and enhancement [13]. If used as a second
staining, it is essential to fix the proteins in the gel withacidic alcohol prior to initial Coomassie blue staining [16].
Two drawbacks of this technique are that proteins are dif-
ferentially sensitive to silver staining and the process may
irreversibly modify them preventing further analysis. In
particular glutaraldehyde, which is generally used during
the sensitization step, may interfere with protein analysis
by MS due to the introduction of covalent cross-links [17].
To circumvent this problem, a glutaraldehyde-free modi-
fied silver-staining protocol has been developed, which is
compatible with both matrix-assisted laser desorption/
ionization (MALDI) and electrospray ionization-MS [17].
Several fluorescent dyes such as Nile red, ruthenium(II)
tris(bathophenantroline disulfonate) (RuBPS), SyPro and
Epicocconone, can also be used to reveal a few ng of pro-
teins in gels [18-20]. CyDyes can even reveal amounts of
protein lower than one nanogram but have the inconveni-
ence of requiring to be incorporated before gel electro-
phoresis [20]. Apart from Nile red, these staining methods
are compatible with subsequent MS analysis. However,
their major disadvantage is that they require a fluores-
cence imager for visualization and that they are signifi-
cantly more expensive than classical colorimetric dyes.
Different alternatives (or additions) to SDS-PAGE exist to
further separate and distinguish the protein of interest from
closely related undesired subproducts or contaminants.
One of them is isoelectric focusing (IEF), which separates
non-denatured proteins based on their isoelectric point,
most often on gel strips. This allows to resolve proteins of
very similar mass, notably unmodified and small molecular
mass post-translationnally modified (e.g. phosphorylated)
variants of a same protein. IEF is often used upstream of
SDS-PAGE in so-called 2D gel electrophoresis [21] .
Capillary electrophoresis (CE) is another useful alterna-
tive, with the advantage of superior separation efficiency,
small sample consumption, short analysis time and auto-
matability. CE separates proteins, with or without prior
denaturation, in slab gels or microfluidic channels, accord-
ing to a variety of properties, including their molecular
mass (SDS-CGE), their isoelectric point (CIEF) or their
electrophoretic mobility (CZE) [22]. Interestingly, CE can
readily be coupled on line with MS [23].
UV-visible spectroscopy UV-visible spectroscopy is most
often used for protein concentration measurements (see
Total protein concentration determination section). How-
ever, it is also a very convenient tool for the detection of
non-protein contaminants, as long as the protein of inter-
est contains aromatic residues and the absorbance is mon-
itored over a large range (at least 240 – 350 nm). In
particular, undesired nucleic acid contaminants can be
spotted as bumps at 260 nm, resulting in a high 260/
280 nm absorbance ratio (which should be close to 0.57
for a non-contaminated protein sample [24]). On the
other hand, reducing agents (especially DTT) alter the
Figure 1 Experimental protein quality control methodological work-flow. A) The properties (purity & integrity, homogeneity, activity) to be
assessed for each new protein sample are listed on the upper left. First-line methods are essential and should be used systematically for a full quality
control assessment. Complementary methods can be added depending on the protein sample peculiarities and quality control requirements. Similarly,
methods for sample optimization monitoring are grouped below in two categories: first-line and complementary. B) The work flow has to be followed
step-by-step starting with the “protein production and purification” green box. For each step, achievement of quality criteria is indicated by a green
arrow (passed) while failure is indicated by a red arrow (failed). In case of failure, process optimization has to be carried out as indicated by black arrows.
Initial sample assessment is sufficient if a sample is only produced once and used directly without storage (orange arrow at the bottom left). In contrast,
if samples have to be stored for an undetermined period of time and produced several times, the sample optimization part of the work-flow should be
performed thoroughly. If no appropriate storage conditions can be found, one should work only with fresh preparations (orange arrow on the right).
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the absorbance at 250 nm and below [25,26].
Mass spectrometry It is essential to verify the integrity
of the protein of interest beyond SDS-PAGE, especially
when setting-up a new production/purification protocol,
as low level proteolysis events (affecting just a few amino
acids) and undesired modifications may go unnoticed in
electrophoresis. The method of choice for detailed analysis
of protein primary structure is MS, as it can provide mo-
lecular mass with 0.01% accuracy for peptides or proteins
with masses up to 500,000 Da using only a few picomoles
of sample [27]. The presence of undesired proteolytic
events and chemical alterations can be readily detected by
comparing the difference between the observed and the ex-
pected mass of the protein. Furthermore MS can provide
detailed information about the presence of desired post-
translational modifications (phosphorylations, acetylations,ubiquitinations, glycosylations, …) [28]. Overall the con-
venience and precision of MS measurements is such that
they should be considered as routine to ensure the integrity
and overall state of modification of the peptide or protein
of interest.
MS-based methods, such as MALDI in-source decay
[29], are progressively replacing traditional protein se-
quencing by Edman degradation [30]. However, N-
terminal Edman sequencing is still of relevance in sev-
eral cases, for instance when one wishes to verify easily
and specifically the N-terminal boundary of the protein
of interest, or when highly accurate masses cannot be
obtained by MS because of the size of the protein or the
presence of certain post-translational modifications [31].
One may also wish to further characterize the degrad-
ation products or contaminants detected by electrophor-
esis, as determining their origin may give clues about how
to avoid them from occurring. Proteins extracted from gel
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tion can be achieved by peptide mass finger-printing, as
the precise peptide pattern that results from the digestion
of a protein by a sequence-specific protease (like trypsin) is
unique for each protein and can be matched by protein-
sequence database search [32]. Usually MALDI time-of-
flight (TOF) spectrometers are used for this type of analysis
because of their speed, mass accuracy and sensitivity. Typ-
ically, proteins detected by Coomassie blue or negative
staining can be identified.Homogeneity
Dynamic light scattering Once the purity and integrity
of the protein sample has been assessed, one has to en-
sure it is homogeneous (Figure 1). Dynamic light scat-
tering (DLS), because of its rapidity and low sample
consumption, is a very convenient method to determine
simultaneously the monodispersity of the species of
interest and the presence of soluble high-order assem-
blies and aggregates [33]. DLS measures Brownian mo-
tion, which is related to the size of the particles. The
velocity of the Brownian motion is defined by a transla-
tional diffusion coefficient that can be used to calculate
the hydrodynamic radius, i.e. the radius of the sphere
that would diffuse with the same rate as the molecule of
interest. This is done by measuring, with an autocorre-
lator, the rate at which the intensity of the light scat-
tered by the sample fluctuates. As a 3 nm radius particle
scatters 1 million times less light than a 60 nm one,
DLS is the method of choice to detect small quantities
of aggregates in a sample [34]. A few percent of large
aggregates may even swamp the scattered light coming
from small particles. It is important to notice that large
particles may also originate from poor buffer prepar-
ation (all protein purification and storage buffers should
systematically be filtered prior to use). Autocorrelation
functions can be mathematically resolved using a variety
of algorithms, developed either by instrument manu-
facturers or academic researchers (for instance Sedfit
[35]). However, the robustness of these mathematical
solutions is fairly poor. Moreover, a precise quantifica-
tion of each individual species is difficult and the reso-
lution of DLS does not allow to resolve close quaternary
structures (for instance monomers from dimers and
small-order oligomers). Overall, DLS is such an easy
and convenient technique that the danger of over-
interpreting its quantitative results is high [34]. How-
ever, the technique is very well adapted for qualitative
studies (which are the focus of this review) and can be
performed over time and/or at different temperatures in
order to test the stability of the protein preparation in
different buffers (see Optimization of homogeneity and
solubility section).UV-visible and fluorescence spectroscopies Although
less sensitive than DLS, UV-visible spectroscopy is also
of use to detect the presence of large particles (with a
hydrodynamic radius higher than 200 nm) in a protein
preparation. This can be done by monitoring the absorb-
ance signal above 320 nm, where aggregate-free protein
samples are not supposed to absorb light, and the signal
can be attributed exclusively to the scattering of light by
large aggregates present in the sample. This simple
measurement can quickly provide qualitative informa-
tion about the sample of interest. If the UV visible signal
is used for concentration measurement, the contribution
of scattering to the overall absorbance can be deduced
by tracing a log-log plot of absorbance versus wave-
length in the 320–350 nm region. This can then be ex-
trapolated to the rest of the spectrum [26,36].
One interesting alternative to UV-visible spectroscopy
is fluorescence spectroscopy [37]. After excitation at
280 nm, the fluorescence emission signal is measured at
280 nm and 340 nm, corresponding respectively to light
scattering and intrinsic protein fluorescence. The ratio
of the intensities at 280 nm and 340 nm (I280/I340) is
concentration independent and purely related to the de-
gree of aggregation of the sample. This ratio, also called
aggregation index (AI), should be close to zero for
aggregate-free protein preparations and can attain high
values (>1) when significant aggregation occurs.
Size-exclusion chromatography As already stressed
above, DLS does not have the sufficient resolution to cor-
rectly assess whether a protein sample is heterogeneous in
terms of oligomerisation. Analytical size exclusion chro-
matography (SEC) is currently the standard separation
technique to quantify protein oligomers. SEC, which very
often is also the last step of protein purification, separates
molecules according to their hydrodynamic size, often de-
fined by their Stokes or hydrodynamic radius [38], with
larger sized molecular species (which are not necessarily
larger molecular mass species) eluting before smaller ones.
Recent developments of the technique have increased the
rapidity of elution, through column parallelization and in-
jection interlacing [39] and/or the use of the latest SEC
columns with smaller pore size, allowing improved reso-
lution with smaller bed volumes, reduced elution times
(below 10 min) and low sample consumption (5 μg in
20 μl) [40-42]. This should encourage people to resort to
SEC as a systematic approach to analyse sample hetero-
geneity. Aggregates, contaminants and potentially different
molecular arrangements of the protein of interest can be
readily separated and quantified, with classical online UV
detection. One should however keep in mind the fact that
the protein sample will be diluted during SEC by as much
as a 10-fold factor, which might alter equilibria between
oligomeric species.
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be, some proteins do interact with them, rendering SEC
impossible. Two column-free separation techniques may
be used as alternatives: asymmetric flow-field flow frac-
tionation (AFFFF), which is also well suited for large mo-
lecular assemblies that may be dissociated by SEC [42,43],
and capillary electrophoresis with electrophoretic mobility
separation (CZE) [22].
Static light scattering Contrary to a widespread belief,
the molecular mass of the species eluted in each SEC peak
cannot be obtained through column calibration approaches,
in which protein standards are separated according to their
hydrodynamic radius and not their molecular mass (the
correlation between both parameters being far from linear,
especially for non-globular and intrinsically disordered pro-
teins). To obtain information about mass, it is necessary to
resort to a static light scattering (SLS) detector [44], in
combination with a UV or a refractive index (RI) detector.
Of note, as in the case of DLS, SLS is also able to detect
small amounts of aggregates with high sensitivity, as the
light scattering signal is proportional to molecular mass
[45]. In size exclusion chromatography with on-line static
laser light scattering (SEC-SLS), experimentally determined
molecular mass is independent of the elution volume of the
protein. Both the total scattered light intensity (which de-
pends on molecular mass and concentration) and the con-
centration of the protein (using the UV or RI detector) are
measured and analysed to determine the molecular mass
of the protein as it elutes from the chromatographic col-
umn. SEC-SLS is applicable and quite accurate over a
broad range of molecular masses (from a few kDa to
several MDa), as long as the column is able to resolve
completely the different species present in the sample,
allowing the area of each peak to be integrated. In order
to improve the separation of peaks with respect to trad-
itional SEC, one can resort to ultra-high performance li-
quid chromatography (UHPLC) systems, which have very
recently been made amenable to SLS. As an alternative,
AFFF can also be used in conjunction with SLS [42,43].
Activity
Active protein concentration determination Once the
homogeneity of the protein of interest has been assessed,
one has to ensure it is active and functional (Figure 1). An
infinite variety of generic or protein-specific functional assays
has been designed, relying principally on catalytic and bind-
ing properties. An attempt at listing such assays would go
much beyond the scope of this review. Efficient assays allow
to measure precisely the active concentration of the protein
sample, and thus to determine (if the total protein concen-
tration is known: see Total protein concentration determin-
ation section) the percentage of purified protein that is
indeed functional. One should not overlook such activeprotein concentration determinations, as it can unfortunately
often be found that the proportion of purified protein which
is indeed in a native active state is low. This can be due to
misfolding issues, to the inability of the protein to reach its
native structural state spontaneously or to interferences of
sequence additions (such as tags or extra amino acids origin-
ating from cloning vectors). But in most cases, this is due to
poor (and overlooked) micro-integrity and homogeneity of
the purified protein (see Purity and integrity section).
Surface plasmon resonance (SPR) is a convenient tech-
nique to determine the active concentration of binding
proteins. This is done by exploiting the properties of diffu-
sion of molecules in continuous flow microfluidic devices
[46,47]. The so-called “calibration-free concentration ana-
lysis” (CFCA) method, which has been implemented in a
user-friendly format in different SPR instruments available
commercially [48], allows to determine the concentration
of protein able to recognize a specific ligand (or protein
partner) tethered on a surface. For CFCA measurements,
the ligand has to be immobilized at high densities, creating
conditions in which the interaction rate of the protein is
limited by its diffusion towards the surface (mass transport
limitation), and becomes proportional to its active concen-
tration [46,47].
Alternatively, if the protein of interest is tagged, one
can resort to a “sandwich” SPR assay to determine directly
what proportion of protein is active: a measurable amount
of protein is first captured through its tag on a surface on
which a tag-specific receptor is immobilized (NTA for His-
tag, or an antibody for others) and then titrated by a satur-
ating amount of specific ligand [49].
Total protein concentration determination Different
methods are available to measure the total protein con-
centration in a sample, allowing to deduce the percent-
age of active protein (see Active protein concentration
determination section). Bradford, bicinchonic acid
(BCA) and Lowry assays use standards for calibration,
which can be a source of error as the composition of the
protein of interest may not necessarily match that of the
protein standards [26]. It is also possible to use UV-
visible absorbance measurements to determine the total
protein concentration as long as its extinction coefficient
is reliably known or calculated [26,50]. The extinction
coefficient at 280 nm is most frequently calculated from
the amino acid composition [25], allowing to determine
concentrations from UV absorbance at this wavelength (see
[26,50] for protocols). However, one should always monitor
wider absorbance spectra (at least from 240 to 350 nm), as
these can provide much more information than concentra-
tion, as already detailed in the two sections referring to
UV-visible spectroscopy above.
However, UV absorbance measurements are only us-
able for concentration determination if the sequence of
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tophans and tyrosines, the two principal light-absorbing
amino acids. If this is not the case, an alternative is to
use Fourier Transform Infrared Spectroscopy (FTIR) as
initially suggest by Etzion et al. [51]. After subtracting
the contribution of water between 1700 nm and 2300 nm,
the analysis of the amide band I and II of the IR absorb-
ance spectrum can be used to calculate protein concentra-
tion by determining the concentration of amine bonds.
Recently, commercially available FTIR equipment has
been developed (Direct Detect from Merck Millipore), ap-
plying this method to protein samples that are dried on a
membrane. The only limitations of the equipment are the
minimal and maximal concentrations that can be used
(0.2 to 5 mg/ml) and the incompatibility of several amine-
containing buffers (HEPES ≥ 25 mM, Tris ≥ 50 mM, …) or
additives (EDTA ≥ 10 mM, …). Another alternative is
amino acid analysis (AAA) which is a very valuable tech-
nique both for protein identification and quantification
[52]. Briefly, quantitative AAA involves hydrolyzing the
peptide bonds to free individual amino acids, which are
then separated, detected and quantified, using purified
amino acids as standards (see [52] for protocol).
Nonetheless, UV-visible spectroscopy remains beyond
any doubt the most widely spread, cost- and time-efficient
technique for total protein concentration determination.
To take full advantage of this technique even in the ab-
sence of tyrosine and tryptophan residues, one solution
can be to use FTIR-based protein quantification and AAA
measurements at first, to generate concentration calibra-
tion curves for the protein of interest in correlation with
UV absorbance (at 280 nm or another wavelength). These
calibration curves can then be used to determine the con-
centration of subsequent samples directly by UV absorb-
ance spectroscopy.
Optimization, stability and reproducibility of protein
samples
Identifying conditions in which a protein sample is
“well-behaved” and meets all the required criteria de-
scribed in Initial sample assessment section is generally
not a trivial task. In this section, we aim at providing an
overview of potential solutions to overcome difficulties
that may arise along the quality control work-flow
(Figure 1). We also discuss how to determine optimal
conditions for the preservation of good quality samples,
and how to ensure that the protein production/purifica-
tion process that one has devised leads reproducibly to
samples of equivalent high quality.
Optimization of purity and integrity
A variety of solutions are available to overcome issues of
contamination of protein samples with impurities, deg-
radation products or undesired chemically-modifiedproteins [53]. These go from changing the purification
protocols (modifying the washing and elution condi-
tions from affinity chromatography columns, or adding
purification steps such as ion-exchange chromatog-
raphy) to more upstream changes such as the addition
of different sets of protease inhibitors, the modification
of the conditions of induction of protein expression,
the choice of another cloning vector (with a different
tag, or a tag placed at another position or at both
ends), or even resorting to another expression host
system.
Optimization of homogeneity and solubility
To remove protein aggregates, it is important to ensure
that the last step of the purification process always is size-
exclusion chromatography. A column should be chosen
that allows elution of the protein of interest well away
from the void volume, and thus total separation from large
protein aggregates. People often need to concentrate their
protein samples in order to attain concentrations high
enough for their downstream applications: unfortunately,
this process, which resorts to spin concentrators or precipi-
tation/resolubilisation protocols, very frequently tends to
induce aggregation. Therefore, one should be careful not
to concentrate their sample more than strictly necessarily
(avoiding overly high concentrations): this should either
be done before the final size-exclusion chromatography
step, or be followed by an analytical SEC or DLS on part
of the concentrated sample to ensure that it has remained
free from aggregates.
To minimize the formation of protein aggregates (and
to improve solubility), a variety of changes can be made
upstream to the production/purification protocol [54]. Ad-
justment of several parameters of the sample buffer com-
position (pH, salinity, presence of additives, co-factors or
ligands, …) can also dramatically increase homogeneity.
People often rely for this on empirical rules that they have
learnt with experience, as there is no clear correlation be-
tween the stability of a protein and its intrinsic properties
(amino acid composition, isoelectric point, secondary
structure elements, …). Recent DLS instrumental develop-
ments, that allow to process a large number of samples in
a 96, 384 or 1536 well plate format, have made buffer con-
dition screening an easy task. Many groups have used DLS
as a technique to improve the solubilisation conditions of
their proteins, in particular before crystallization studies
[55,56]. Buffer matrices for multi-parametric screening of
pH, salinity, buffer nature, additives and co-factors can be
generated by hand or using simple robotics [57]. Typically
samples, at a concentration of 10 mg/ml for a 10 kDa pro-
tein or 1 mg/ml for a 100 kDa protein, are diluted 10
times in each test buffer with a consumption of only 2 μl
of sample per condition. The homogeneity of the sam-
ple and the presence of aggregates (and high-order
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in each condition, allowing to select the optimal buffer
composition for protein homogeneity.
Optimization of protein sample stability and storage
Preservation of good quality protein samples over time is
all important, as very often one will not consume all of a
sample straight away. People most often rely on hearsay
for the short-term or long-term storage of their precious
protein samples. A very widely spread belief is that flash
freezing (with or without cryoprotectants such as glycerol)
is the best method for long-term retention of protein
properties. However, this is far from being a general truth,
especially because significant denaturation, aggregation
and precipitation can occur upon freezing/thawing [58].
Proteins may become unstable and lose their biological ac-
tivity through a variety of physical or chemical mecha-
nisms, even at cold temperatures [59-61]. The best storage
conditions are very much protein-dependent, and may
vary from unfrozen aqueous solutions to salted precipi-
tates or freeze-dried solids [59-61].
A practical way to approach this issue is to start by
monitoring the time stability of one’s protein sample at a
few relevant temperatures (e.g. 4 and 25°C) using DLS and
a functional assay, in the optimal buffer for sample homo-
geneity and solubility (see Optimization of homogeneity
and solubility section). Indeed, one may quite often realize
this way that simple storage of the protein sample without
further processing (for instance at 4°C) provides long
enough stability for all down-stream experiments.
Many people also evaluate the thermal stability of their
proteins in different buffers, using methods such as differ-
ential scanning fluorimetry (DSF, also known as thermal-
shift assay) [57]: however, there is no clear correlation be-
tween thermodynamic and time stability of a protein, and
it is therefore not straightforward to obtain insight about
the long-term stability of a sample from its thermal stabil-
ity analysis. On the contrary, thermodynamic stability gen-
erally correlates with rigidity [62], which is of particular
importance when the downstream application is structural
characterization (for instance by X-ray crystallography).
If a protein needs to be stored for an undetermined
period, one can explore different methods (freezing with or
without cryoprotectants, lyophilization,… [59-61]) and de-
termine their effect on the properties of the sample using
DLS and a functional assay. Of note, the best storage con-
ditions may be largely different from the experimental con-
ditions for downstream applications, so a preliminary
desalting or dialysis might be needed before quality control.
Determination of protein sample reproducibility and
lot-to-lot consistency
A fundamental principle of good laboratory practices is
that experiments need to be reproduced and should thusbe reproducible, both within a laboratory and between re-
search groups. During the lifetime of a project, it is there-
fore very likely that one will need to prepare more than a
single sample of a given protein. Other groups might also
need to prepare it independently in the frame of collabora-
tions or comparability studies. Determining the robustness
of one’s production/purification process and its capacity to
reproducibly deliver samples of equivalent quality is there-
fore all-important. However, once the quality of a purified
protein sample has been fully assessed and optimized a
first time, verification of lot-to-lot consistency does not
necessarily require the repetition of the whole quality con-
trol work-flow (Figure 1B).
A very practical way to rapidly estimate the equiva-
lence of protein lots is to verify the conformity of their
“spectral signatures”. The most straightforward is to
compare UV-visible spectra which, as has been stressed
above, contain a wealth of information beyond simple
280 nm absorbance. This may be profitably complemen-
ted by circular dichroism (CD) in the far-UV, which pro-
vides information about the global content of secondary
structure elements in a protein [63,64]. Of note, contrary
to a widespread belief, the presence of secondary struc-
ture elements in a protein (“foldedness”) is not by itself a
quality control criterium, especially as many proteins are
either intrinsically disordered or contain unfolded seg-
ments in their native state. But differences between the
CD spectra acquired for two different lots of the same
protein (in the same buffer) may readily reveal diver-
gences in folding that could correlate with differences in
active concentration, especially if spectral similarity is
analysed quantitatively rather than visually [65,66].
“Thermal denaturation signatures”, determined by tech-
niques such as CD or differential scanning calorimetry
(DSC, [67]), can also be a very convenient and accurate
way to determine the equivalence of protein lots, provided
special attention is given to the equivalence of protein
sample conditioning buffers. Indeed, differences between
protein lots can translate into detectable differences in the
global shape of their denaturation profiles [68].
Apart from spectral and thermal denaturation signa-
tures, MS (for integrity), DLS (for homogeneity), analyt-
ical SEC (for both purity and homogeneity) and a
functional assay are the most convenient and discrimin-
ating methods to assess the reproducibility and equiva-
lence in quality of distinct protein lots.
Conclusion
In this review, we have attempted to cover all the as-
pects of protein quality control, from the necessary ini-
tial sample assessment to sample optimization. For each
step, a set of relevant techniques has been suggested
(Figure 1A). The first-line methods are essential and
should be used systematically for a full quality control
Raynal et al. Microbial Cell Factories  (2014) 13:180 Page 8 of 10assessment. Different complementary methods can be
added depending on the protein sample peculiarities and
quality control requirements. The suggested approaches
for first line assessment include the “basic requirements
for evaluating protein quality” that have been recently pro-
posed [10], but go significantly beyond them. We also sug-
gest a sequential experimental work-flow, to be followed
as a check-list in order to optimize the time and effort
spent on each sample (Figure 1B). This work-flow elabo-
rates the protein quality control and storage optimization
steps of the general protein production/purification pipe-
line [10]. Overall, this global synthetic step-by-step over-
view should hopefully lead to better protein samples and
therefore to better chances of success in downstream
applications. In line with community-based efforts that
have been deployed in other fields like structural biol-
ogy [69,70], proteomics and interactomics [71-74] or
quantitative real-time PCR [75,76], research relying on
purified proteins would gain significant reliability and
credibility from the implementation of good practices,
such as the systematic and transparent reporting of the
results of purified protein quality control assessments,
at least in the supplementary information sections of
scientific publications.
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